12
Participants
Start Date
October 18, 2019
Primary Completion Date
July 30, 2021
Study Completion Date
March 15, 2022
HydraSolve T2D™
The HydraSolve T2D™ System will be used to perform the combined minimally invasive laparoscopic and mini-laparotomy procedure to selectively extract excess intra-abdominal fat from the mesentery. All patients will receive standard nutritional counseling and their medications will be adjusted to achieve target levels of blood glucose control.
RECRUITING
University of Texas Health Science Center at San Antonio, San Antonio
Lead Sponsor
Medality Medical
INDUSTRY